•
Dec 31, 2018

Lexicon Pharmaceuticals Q4 2018 Earnings Report

Total Revenue
$17.1M
Previous year: $33M
-48.3%
EPS
-$0.16
Previous year: -$0.23
-30.4%
Research and development expenses
$12.3M
Selling, general and admin expenses
$16.6M
Gross Profit
$16.5M
Previous year: $32.5M
-49.2%
Cash and Equivalents
$80.4M
Previous year: $61.7M
+30.4%
Free Cash Flow
-$27.2M
Previous year: -$33.7M
-19.4%
Total Assets
$284M
Previous year: $437M
-34.9%

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals